Showing results (691-700 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|September 3, 2013
Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approachesMichael J Gramer, Ewald T J van den Bremer, Muriel D van Kampen, et al.Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.Mabs|September 3, 2013
Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatographyRachel B Wollacott, Paul L Casaz, Trevor J Morin, et al.Mabs|June 20, 2013
A strategy for risk mitigation of antibodies with fast clearanceIsidro Hötzel, Frank-Peter Theil, Lisa J Bernstein, et al.Mabs|July 11, 2013
Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometryHeather Lynaugh, Huijuan Li, Bing GongMabs|July 13, 2013
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitisDilip K Challa, Uta Bussmeyer, Tarique Khan, et al.Mabs|April 10, 2013
Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicityYang Shen, Lin Zeng, Aiping Zhu, et al.Mabs|April 11, 2013
Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and developmentTudor Arvinte, Caroline Palais, Erin Green-Trexler, et al.Mabs|June 12, 2013
Characterization of a surrogate murine antibody to model anti-human CD3 therapiesFabien Dépis, Eric Hatterer, Romain Ballet, et al.Pageof 180